#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Familial hypertriglyceridaemia Craniopharyngioma Ocular lymphoma Nephrotic syndrome Dermatitis Small cell lung cancer extensive stage Uterine leiomyosarcoma Mantle cell lymphoma stage IV Noonan syndrome Necrotising enterocolitis neonatal Immune-mediated myasthenia gravis Carcinoid tumour Hypersensitivity pneumonitis Hypertriglyceridaemia Inflammatory myofibroblastic tumour More trials…

    Learn about Rare Diseases

    Castleman’s disease – Basic Information Osteosarcoma metastatic – Trials in Disease Amyotrophic lateral sclerosis Wolfram syndrome – Basic Information Angiosarcoma metastatic – Treatment Systemic sclerosis pulmonary Glycogen storage disease type II – Diagnostics Progressive supranuclear palsy – Life with Disease Nodal marginal zone B-cell lymphoma – Basic Information Idiopathic pulmonary fibrosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Umeclidinium Bromide Nirmatrelvir Abiraterone Acetate Celecoxib Afamelanotide Fampridine Taxanes Xylitol Cariprazine [18F]Fluoro-Peg-Folate Etanercept Deflazacort Azithromycin Dihydrate Ulipristal Acetate Ripretinib Mirikizumab Lansoprazole Mps-200 S230815-2 2-DEOXY-D-GLUCOSE More therapies…

    Learn about Your Condition

    Brain neoplasm malignant Multiple sclerosis relapse Cervical dysplasia Breast cancer stage III Wiskott-Aldrich syndrome Hypersomnia Gouty arthritis Acute hepatic failure Colorectal adenoma Vasospasm Pneumonia Arterial stiffness Von Willebrand's disease Hereditary optic atrophy Endometrial cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Oxytocin Treatment for Children with Autism and Intellectual Disability

    Recruiting

    3 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study of Botulinum Toxin and Saline Solution for Erectile Dysfunction in Patients Unresponsive to Standard Treatments

    Recruiting

    2 1 1
    Investigated Diseases:
    • Erectile dysfunction
    Investigated Drugs:
    • Sodium Chloride Solution 0.9%
    Spain

  • Study on Adjusting Adalimumab Dosage for Patients with Rheumatoid Arthritis in Remission

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Adalimumab
    France

  • Study on Golcadomide and Valemetostat Tosylate for Patients with Relapsed or Refractory Non-Hodgkin Lymphomas

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Valemetostat Tosilate
    • Golcadomide
    • Rituximab
    Denmark France Italy Spain

  • Study on Maintenance Therapy with Durvalumab and Olaparib for Patients with Extensive Disease Small-Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Durvalumab
    • Olaparib
    Germany

  • Study on Coagulation Differences Using Fresh Frozen Plasma and Solvent-Detergent Plasma in Children Undergoing Congenital Heart Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Coagulopathy
    Investigated Drugs:
    • Human Plasma Protein
    • Plasma
    The Netherlands
Previous Page
1 … 377 378 379 380 381 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!